(1)
Papp, K. A.; Yeung, J.; Shear, N.; Albrecht, L.; Lynde, C.; Zhang, J.; Zhao, Y.; Parno, J.; Mendelsohn, A. M.; Gooderham, M. Early and Maintained Response Levels in Psoriasis Patients Treated With Tildrakizumab. J of Skin 2020, 4, s41.